SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CareMax, Inc. (CMAX) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+516.8%).
- Analyst consensus target $2.60 (+516.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 36/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CMAX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-183.30
Book Value / Share$0.00
Revenue / Share$201.47
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$2.60 (+516.8%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$9.64 |
$72.38M |
$3.47M |
4.8% |
| 2019 |
$0.00 |
$90.6M |
$6.02M |
6.6% |
| 2020 |
$16.51 |
$103.42M |
$5.94M |
5.7% |
| 2021 |
$-3.81 |
$295.76M |
$-6.68M |
-2.3% |
| 2022 |
$-12.49 |
$631.13M |
$-37.8M |
-6% |
| 2023 |
$-183.30 |
$751.1M |
$-683.35M |
-91% |
